Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
Yuki TahataHayato HikitaSatoshi MochidaNobuyuki EnomotoAkio IdoHidekatsu KurodaDaiki MikiMasayuki KurosakiYoichi HiasaRyotaro SakamoriNorifumi KawadaTaro YamashitaGoki SudaHiroshi YatsuhashiHitoshi YoshijiNaoya KatoTaro TakamiKazuhiko NakaoKentaro MatsuuraYasuhiro AsahinaYoshito ItohRyosuke TateishiYasunari NakamotoEiji KakazuShuji TeraiMasahito ShimizuYoshiyuki UenoNorio AkutaMasanori MiyazakiYasutoshi NozakiMasayuki KabayamaSatoshi SobueAkihiro MoriuchiTomokatsu MiyakiTakahiro KodamaTomohide TatsumiTomomi YamadaTetsuo TakeharaPublished in: Journal of gastroenterology (2023)
The prognosis of decompensated cirrhotic patients receiving DAA was stratified by liver function at 12 weeks after the EOT, not by baseline liver function.